NIH AI/ML Consortium to Advance Health Equity and Researcher Diversity (AIM-AHEAD) Program Awards Grant to MedCognetics to Research Unbiased AI for Breast Cancer Detection

MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded a $750,000 grant from the National Institute of Health (NIH) to research unbiased AI for breast cancer detection. The research grant is from the NIH’s Artificial Intelligence/Machine Learning Consortium to Advance Health Equity and Researcher Diversity, or AIM-AHEAD program.

Related Keywords

Dallas ,Texas ,United States ,Fort Worth ,University Of Texas Southwestern Medical Center ,Jamboor Vishwanatha ,Quality Of Life Technology Laboratory ,University Of Texas At Dallas ,National Institutes Of Health ,Health Science Center At Fort Worth ,Researcher Diversity Program ,Drug Administration ,Medcognetics Inc ,University Of North Texas Health Science Center ,University Of North Texas ,Artificial Intelligence ,National Institutes ,Machine Learning Consortium ,Advance Health Equity ,Machine Learning ,North Texas Health Science Center ,Regents Professor ,North Texas ,Health Science Center ,Life Technology Laboratory ,Texas Southwestern Medical Center ,Debasish Nag ,Chief Executive Officer ,